Navigation Links
Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis

Schlieren (Zurich), Switzerland, May 24, 2007 - Cytos Biotechnology AG (SWX:CYTN) reported today results from a placebo-controlled, double-blind combined phase I/IIa study with CYT007-TNFQb, a novel vaccine candidate for the treatment of psoriasis and other inflammatory conditions. The present study was a first-time-in-man clinical trial and included 48 patients suffering from moderate to severe plaque psoriasis. In a first part of the study, the safety and tolerability of ascending doses of CYT007-TNFQb were assessed in 24 patients. In the following second part of the study, the exploratory efficacy of the highest vaccine dose was compared to placebo in another 24 patients.

All doses of CYT007-TNFQb tested were safe and well tolerated. All the patients who received the vaccine mounted an antibody response against TNF-?. Exploratory efficacy was assessed according to the Psoriasis Area and Severity Index (PASI), a commonly used measure to evaluate the disease severity in psoriatic patients. The graph below shows the course of the PASI scores throughout the study period (i.e. from baseline up to week 16) for the CYT007-TNFQb-treated and the placebo group.


SEE ATTACHMENT FOR CHART

Dr. Wolfgang Renner, CEO of Cytos Biotechnology, commented the study results: “The prime objective of this first-time-in-man clinical trial was to demonstrate safety and tolerability of this novel vaccine candidate. This objective was clearly reached. With regard to efficacy we are seeing a temporary improvement of the disease. We will now in detail analyse a broad set of biochemical markers in order to determine whether this observed improvement of disease is indeed treatment related. This additional analytical and laboratory work, which will take several months to complete, will then guide us in the further development of this novel vaccine candidate.”

Cytos Biotechnology will discuss the development program for CYT007-TNFQb
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:10/30/2014)... Oct. 29, 2014  BioMed Realty Trust, Inc. (NYSE: ... company focusing on life sciences, today announced financial ... 2014. Third Quarter 2014 Highlights Financial ... leasing transactions during the quarter representing approximately 657,700 ... for the third quarter of approximately 219,700 square ...
(Date:10/27/2014)... Oct. 27, 2014  RenovoRx, a leading developer of ... delivery of fluids to selected sites in the vascular ... has appointed Shaun Bagai as Chief Executive ... Board of Directors. Bagai brings more than 15 years ... Bagai joined RenovoRx in June 2014 and in his ...
(Date:10/27/2014)... , Oct. 27, 2014 Research and ... H1N1 Vaccines Market 2014-2018" report to their offering. ... humans caused by a variant of the swine H1N1 virus, ... virus which infects nose, throat, and lungs. H1N1 virus is ... viruses infect different animal species such as humans, swine, birds, ...
Breaking Medicine Technology:BioMed Realty Trust Reports Third Quarter 2014 Financial Results 2BioMed Realty Trust Reports Third Quarter 2014 Financial Results 3BioMed Realty Trust Reports Third Quarter 2014 Financial Results 4BioMed Realty Trust Reports Third Quarter 2014 Financial Results 5BioMed Realty Trust Reports Third Quarter 2014 Financial Results 6BioMed Realty Trust Reports Third Quarter 2014 Financial Results 7BioMed Realty Trust Reports Third Quarter 2014 Financial Results 8BioMed Realty Trust Reports Third Quarter 2014 Financial Results 9BioMed Realty Trust Reports Third Quarter 2014 Financial Results 10BioMed Realty Trust Reports Third Quarter 2014 Financial Results 11BioMed Realty Trust Reports Third Quarter 2014 Financial Results 12BioMed Realty Trust Reports Third Quarter 2014 Financial Results 13BioMed Realty Trust Reports Third Quarter 2014 Financial Results 14BioMed Realty Trust Reports Third Quarter 2014 Financial Results 15BioMed Realty Trust Reports Third Quarter 2014 Financial Results 16BioMed Realty Trust Reports Third Quarter 2014 Financial Results 17BioMed Realty Trust Reports Third Quarter 2014 Financial Results 18BioMed Realty Trust Reports Third Quarter 2014 Financial Results 19BioMed Realty Trust Reports Third Quarter 2014 Financial Results 20BioMed Realty Trust Reports Third Quarter 2014 Financial Results 21RenovoRx Board Names Shaun R. Bagai as CEO 2Global H1N1 Vaccines Market 2014-2018: Key Vendors are AstraZeneca, GlaxoSmithKline, Novartis and Sanofi Pasteur 2Global H1N1 Vaccines Market 2014-2018: Key Vendors are AstraZeneca, GlaxoSmithKline, Novartis and Sanofi Pasteur 3
... , FRANKLIN, Mass., Sept. 14 PLC ... cardiac and vascular medical device-based technologies, today announced that a paper ... in conjunction with autologous stem cells was presented at ESC Congress ... Barcelona, Spain. , , This study ...
... ORLANDO, Florida, September 14 ... Clinical Surveillance System Will Help Novant,Hospitals Ensure Patient Safety ... MEDai, Inc., an Elsevier company and leading provider ... today that Novant Health, a not-for-profit integrated group of,hospitals ...
Cached Medicine Technology:Study on PLC Systems' TMR Therapy With Stem Cells Presented at ESC 2009 2Study on PLC Systems' TMR Therapy With Stem Cells Presented at ESC 2009 3Novant Health Rolls Out MEDai's Predictive Modeling Solution to Nine Hospitals in Three States 2Novant Health Rolls Out MEDai's Predictive Modeling Solution to Nine Hospitals in Three States 3Novant Health Rolls Out MEDai's Predictive Modeling Solution to Nine Hospitals in Three States 4
(Date:10/30/2014)... HealthDay Reporter , WEDNESDAY, Oct. 29, ... been identified that appear linked to autism spectrum disorders, ... are on their way to discovering up to 1,000 ... Autism spectrum disorders include a range of developmental disabilities ... An estimated one in 68 U.S. children has an ...
(Date:10/30/2014)... 30, 2014 Horse Sense & ... riding to special needs individuals in the Jacksonville area, ... November 15 from 10-2:00 p.m. at Bailey's Farm (2202 ... to the public and is designed to raise awareness ... to the HSS Round-Up is free. Ticket purchases will ...
(Date:10/30/2014)... 30, 2014 The human brain is ... vigorously exercised to help maintain better mental health, according ... ‘Dementia Express: Lose Your Memory in 100 Ways’ for ... and sometimes conflicting attitudes to help keep the reader ... a reader must decipher the hidden logic within. , ...
(Date:10/30/2014)... 29, 2014 (HealthDay News) -- When it comes to heart ... men to delay care when they have symptoms that spell ... to the hospital with a more severe or advanced stage ... study author Catherine Kreatsoulas, a Fulbright Scholar and research fellow ... news release from the Heart and Stroke Foundation of Canada. ...
(Date:10/30/2014)... Many U.S. colleges have indoor tanning salons on ... risk for skin cancer, researchers report. Tanning ... so colleges should adopt tanning-free policies, to help ... health efforts are needed to raise university administration ... indoor tanning poses to young adults in order ...
Breaking Medicine News(10 mins):Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 3Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2Health News:‘Dementia Express’ Offers Contradictory and Sometimes Reverse Thinking, All to Keep its Reader on Their Toes With an Active Mind. 2Health News:Women Often Ignore Signs of Heart Trouble 2Health News:Many U.S. Colleges Have Indoor Tanning Salons On, Near Campus: Study 2
... Alcohol Support Team Board of Directors and Commits all ... Corporate Charity Work to Benefit FASTeam, ... a year, more than Spina Bifida, Down Syndrome and Muscular,Dystrophy ... an,increase in efforts to promote prevention of prenatal alcohol exposure ...
... LAKE FOREST, Ill., July 7 Hospira, Inc.,(NYSE: ... today announced that it will host a conference call ... 2008, at 8 a.m. Central,time., The company will ... stock market open and the conference call., A ...
... 100%, ARLINGTON HEIGHTS, Ill., July 7 ... are satisfied with,their decision, have low complication rates ... study in July,s Plastic and Reconstructive Surgery(R), the,official ... Surgeons,(ASPS). In addition, breast reconstruction after preventive mastectomy ...
... 2 should be tested for high cholesterol, group says , , ... to the impact of the childhood obesity epidemic in the ... kids as young as 8 years old be given cholesterol-lowering ... , The American Academy of Pediatrics also recommends that children ...
... AIDS Fundraising Event Goes GREEN with Online ... Communications, Recycling and Awareness, SAN FRANCISCO, July ... Francisco announced today key initiatives to ,Green, the,HIV fundraising event ... introduction of Green Walkers, composting, and,enhanced recycling., "With the ...
... MEETING, Pa., July 7 /Xinhua-PRNewswire/ -- BMP ... ,Company,) today,announced that it received the New ... enterprise with foreign investment in the People,s,Republic ... Industry and,Commerce (SHAIC). With receipt of this ...
Cached Medicine News:Health News:K Squared Sponsors F.A.S.T. Ride 150-mile Motorcycle Tour August 17 2Health News:98% of Elective Mastectomy Patients Would Have Reconstruction Again, Says ASPS Study 2Health News:Pediatricians Recommend Cholesterol Drugs for Some Kids 2Health News:Pediatricians Recommend Cholesterol Drugs for Some Kids 3Health News:AIDS Walk San Francisco Takes Big Green Step Forward 2Health News:AIDS Walk San Francisco Takes Big Green Step Forward 3Health News:BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd 2
Pediatric model. Blades: 10 mm. Solid blades with locking mechanism. Dull finish....
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish....
... The Kawesch-Lancaster Lasik speculum ... one curved to provide clearance ... solid blades retract the lids ... path for the microkeratome. The ...
Medicine Products: